Rankings
▼
Calendar
NXTC Q2 2021 Earnings — NextCure, Inc. Revenue & Financial Results | Market Cap Arena
NXTC
NextCure, Inc.
$35M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$18M
Net Income
-$18M
EPS (Diluted)
$-7.82
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$275M
Total Liabilities
$12M
Stockholders' Equity
$264M
Cash & Equivalents
$35M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$18M
-$16M
-13.6%
Net Income
-$18M
-$15M
-24.0%
← FY 2021
All Quarters
Q3 2021 →